Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -45.28 | 150.30 | -193.20 | 172.26 |
Depreciation/ Depletion | 125.64 | 112.81 | 94.68 | 69.84 |
Non- Cash Items | 430.45 | 44.92 | 536.75 | 75.18 |
Changesin Working Capital | -12.93 | -131.40 | -406.37 | -186.16 |
Cashfrom Operating Activities | 497.88 | 176.63 | 31.85 | 131.13 |
Capital Expenditures | -311.41 | -328.79 | -257.58 | -82.81 |
Other Investing Cash Flow Items Total | -19.01 | 24.09 | 22.76 | -26.58 |
Cashfrom Investing Activities | -330.42 | -304.70 | -234.82 | -109.39 |
Financing Cash Flow Items | -43.44 | -40.44 | -8.91 | -5.02 |
Issuance( Retirement)of Debt Net | -64.58 | 164.98 | 244.95 | -86.44 |
Cashfrom Financing Activities | -108.02 | 124.54 | 236.04 | -91.46 |
Net Changein Cash | 59.44 | -3.53 | 33.07 | -69.72 |
Cash Interest Paid | 43.44 | 40.44 | 8.91 | 5.02 |
Cash Taxes Paid | 62.42 | 97.06 | 54.82 | 45.55 |
Akums Drugs And Pharmaceuticals Dividend Akums Drugs And Pharmaceuticals Bonus Akums Drugs And Pharmaceuticals News Akums Drugs And Pharmaceuticals AGM Akums Drugs And Pharmaceuticals Rights Akums Drugs And Pharmaceuticals Splits Akums Drugs And Pharmaceuticals Board Meetings Akums Drugs And Pharmaceuticals Key Metrics Akums Drugs And Pharmaceuticals Shareholdings Akums Drugs And Pharmaceuticals Profit Loss Akums Drugs And Pharmaceuticals Balance Sheet Akums Drugs And Pharmaceuticals Q1 Results Akums Drugs And Pharmaceuticals Q2 Results Akums Drugs And Pharmaceuticals Q3 Results Akums Drugs And Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks